126 related articles for article (PubMed ID: 29575112)
1. The what, when, and why of human prostate cancer xenografts.
Brennen WN; Isaacs JT
Prostate; 2018 Jun; 78(9):646-654. PubMed ID: 29575112
[TBL] [Abstract][Full Text] [Related]
2. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
3. Xenografts of primary human prostatic carcinoma.
Pretlow TG; Wolman SR; Micale MA; Pelley RJ; Kursh ED; Resnick MI; Bodner DR; Jacobberger JW; Delmoro CM; Giaconia JM
J Natl Cancer Inst; 1993 Mar; 85(5):394-8. PubMed ID: 8433392
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer xenografts and hormone induced prostate carcinogenesis.
McLean DT; Strand DW; Ricke WA
Differentiation; 2017; 97():23-32. PubMed ID: 28923776
[TBL] [Abstract][Full Text] [Related]
5. The future of patient-derived xenografts in prostate cancer research.
Lawrence MG; Taylor RA; Cuffe GB; Ang LS; Clark AK; Goode DL; Porter LH; Le Magnen C; Navone NM; Schalken JA; Wang Y; van Weerden WM; Corey E; Isaacs JT; Nelson PS; Risbridger GP
Nat Rev Urol; 2023 Jun; 20(6):371-384. PubMed ID: 36650259
[TBL] [Abstract][Full Text] [Related]
6. Establishing prostate cancer patient derived xenografts: lessons learned from older studies.
Russell PJ; Russell P; Rudduck C; Tse BW; Williams ED; Raghavan D
Prostate; 2015 May; 75(6):628-36. PubMed ID: 25560784
[TBL] [Abstract][Full Text] [Related]
7. Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.
Porter LH; Lawrence MG; Wang H; Clark AK; Bakshi A; Obinata D; Goode D; Papargiris M; Mural ; Clouston D; Ryan A; Norden S; Corey E; Nelson PS; Isaacs JT; Grummet J; Kourambas J; Sandhu S; Murphy DG; Pook D; Frydenberg M; Taylor RA; Risbridger GP
Prostate; 2019 Aug; 79(11):1326-1337. PubMed ID: 31212368
[TBL] [Abstract][Full Text] [Related]
8. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived xenografts: A platform for accelerating translational research in prostate cancer.
Davies AH; Wang Y; Zoubeidi A
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):17-24. PubMed ID: 28315377
[TBL] [Abstract][Full Text] [Related]
10. Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance.
Lam HM; Nguyen HM; Corey E
Methods Mol Biol; 2018; 1786():1-27. PubMed ID: 29786784
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
[TBL] [Abstract][Full Text] [Related]
12. High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.
Lin D; Wyatt AW; Xue H; Wang Y; Dong X; Haegert A; Wu R; Brahmbhatt S; Mo F; Jong L; Bell RH; Anderson S; Hurtado-Coll A; Fazli L; Sharma M; Beltran H; Rubin M; Cox M; Gout PW; Morris J; Goldenberg L; Volik SV; Gleave ME; Collins CC; Wang Y
Cancer Res; 2014 Feb; 74(4):1272-83. PubMed ID: 24356420
[TBL] [Abstract][Full Text] [Related]
13. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.
Wainstein MA; He F; Robinson D; Kung HJ; Schwartz S; Giaconia JM; Edgehouse NL; Pretlow TP; Bodner DR; Kursh ED
Cancer Res; 1994 Dec; 54(23):6049-52. PubMed ID: 7525052
[TBL] [Abstract][Full Text] [Related]
14. Establishment and serial passage of cell cultures derived from LuCaP xenografts.
Young SR; Saar M; Santos J; Nguyen HM; Vessella RL; Peehl DM
Prostate; 2013 Sep; 73(12):1251-62. PubMed ID: 23740600
[TBL] [Abstract][Full Text] [Related]
15. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
[TBL] [Abstract][Full Text] [Related]
16. Establishment of short-term primary human prostate xenografts for the study of prostate biology and cancer.
Presnell SC; Werdin ES; Maygarden S; Mohler JL; Smith GJ
Am J Pathol; 2001 Sep; 159(3):855-60. PubMed ID: 11549578
[TBL] [Abstract][Full Text] [Related]
17. Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer.
Valta MP; Zhao H; Saar M; Tuomela J; Nolley R; Linxweiler J; Sandholm J; Lehtimäki J; Härkönen P; Coleman I; Nelson PS; Corey E; Peehl DM
Clin Exp Metastasis; 2016 Apr; 33(4):325-37. PubMed ID: 26873136
[TBL] [Abstract][Full Text] [Related]
18. Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.
Saar M; Körbel C; Linxweiler J; Jung V; Kamradt J; Hasenfus A; Stöckle M; Unteregger G; Menger MD
Prostate; 2015 Oct; 75(14):1526-37. PubMed ID: 26074274
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts.
El-Hoss J; Jing D; Evans K; Toscan C; Xie J; Lee H; Taylor RA; Lawrence MG; Risbridger GP; MacKenzie KL; Sutton R; Lock RB
Oncotarget; 2016 Sep; 7(37):60475-60490. PubMed ID: 27528024
[TBL] [Abstract][Full Text] [Related]
20. Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy.
Press JZ; Kenyon JA; Xue H; Miller MA; De Luca A; Miller DM; Huntsman DG; Gilks CB; McAlpine JN; Wang YZ
Gynecol Oncol; 2008 Aug; 110(2):256-64. PubMed ID: 18547621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
